These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9609221)

  • 41. Glycemic variation in uncontrolled Graves' disease patients with normal glucose metabolism: Assessment by continuous glucose monitoring.
    Gao G; Li FF; Hu Y; Yan RN; Liu BL; Liu XM; Su XF; Ma JH; Hu G
    Endocrine; 2019 May; 64(2):265-270. PubMed ID: 30515677
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Graves' disease following thyroid therapy.
    Paz AT; Zellmann HE; Bell GO
    Lahey Clin Found Bull; 1969; 18(1):11-6. PubMed ID: 5818429
    [No Abstract]   [Full Text] [Related]  

  • 43. Thrombocytopenia in Graves' disease: effect of T3 on platelet kinetics.
    Kurata Y; Nishioeda Y; Tsubakio T; Kitani T
    Acta Haematol; 1980; 63(4):185-90. PubMed ID: 6771949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated plasma adrenomedullin level in hyperthyroidism.
    Taniyama M; Kitamura K; Ban Y; Eto T; Katagiri T
    Eur J Clin Invest; 1996 Jun; 26(6):454-6. PubMed ID: 8817157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Graves' disease shows a significant increase in the Helicobacter pylori recurrence.
    Bassi V; Fattoruso O; Polistina MT; Santinelli C
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):784-5. PubMed ID: 24444387
    [No Abstract]   [Full Text] [Related]  

  • 46. Hyperthyroidism (Graves' disease).
    Castiglia PT
    J Pediatr Health Care; 1997; 11(5):227-9. PubMed ID: 9369640
    [No Abstract]   [Full Text] [Related]  

  • 47. [Thyroid hormone binding with blood plasma lipoprotein fractions in coronary arteriosclerosis].
    Livshits IB; Sherstiuk GV
    Lab Delo; 1980; (7):409-12. PubMed ID: 6157867
    [No Abstract]   [Full Text] [Related]  

  • 48. Food choice in hyperthyroidism: potential influence of the autonomic nervous system and brain serotonin precursor availability.
    Pijl H; de Meijer PH; Langius J; Coenegracht CI; van den Berk AH; Chandie Shaw PK; Boom H; Schoemaker RC; Cohen AF; Burggraaf J; Meinders AE
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5848-53. PubMed ID: 11739450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Influences of Graves' disease on pregnant women, their fetuses and neonates (author's transl)].
    Sugimoto M; Mizuno M
    Horumon To Rinsho; 1981 Jul; 29(7):773-81. PubMed ID: 6895489
    [No Abstract]   [Full Text] [Related]  

  • 50. [The cause of the high plasma iodotyrosine level in Basedow's disease].
    Földes J; Takó J; Bános C; Gesztesi E
    Orv Hetil; 1969 Oct; 110(41):2377-9. PubMed ID: 5395310
    [No Abstract]   [Full Text] [Related]  

  • 51. Graves' disease in the Inuit population of Greenland. Presentation of five cases observed during a two month period.
    Andersen S; Hvingel B; Laurberg P
    Int J Circumpolar Health; 1999 Oct; 58(4):248-52; discussion 252-3. PubMed ID: 10615830
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Changes in sexual activity and serum hormone concentrations in male patients with Graves' disease].
    Luo GC; Li JY; Guo AY
    Zhonghua Nei Ke Za Zhi; 1987 Sep; 26(9):520-2, 564. PubMed ID: 3450471
    [No Abstract]   [Full Text] [Related]  

  • 53. [Serum lipoproteins in disorders of thyroid function].
    Richter V; Rassoul F; Homann M; Zuck U; Rotzsch W
    Z Med Lab Diagn; 1987; 28(8):415-20. PubMed ID: 3439269
    [No Abstract]   [Full Text] [Related]  

  • 54. [Post-operative thyroid storm treated by plasmapheresis (author's transl)].
    Martin C; Auffray JP; Rocca B; Dumas D; Gouin F
    Anesth Analg (Paris); 1981; 38(11-12):713-5. PubMed ID: 6896800
    [No Abstract]   [Full Text] [Related]  

  • 55. Plasma insulin disappearance curve after intravenous insulin injection in human hyperthyroidism.
    Wajchenberg BL; Cesar FP; Leme CE; Didio R; Kieffer J
    Clin Endocrinol (Oxf); 1978 Mar; 8(3):233-6. PubMed ID: 580416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Blood serum beta lipoproteins in thyroid gland diseases].
    Slukhaĭ IuF
    Probl Endokrinol (Mosk); 1968; 14(2):52-4. PubMed ID: 5757164
    [No Abstract]   [Full Text] [Related]  

  • 57. Hemostasis in Overt and Subclinical Hyperthyroidism.
    Ordookhani A; Burman KD
    Int J Endocrinol Metab; 2017 Jul; 15(3):e44157. PubMed ID: 29201071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism.
    Erem C; Ucuncu O; Yilmaz M; Kocak M; Nuhoglu İ; Ersoz HO
    Endocrine; 2009 Dec; 36(3):473-8. PubMed ID: 19859836
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemostasis and thyroid diseases revisited.
    Franchini M
    J Endocrinol Invest; 2004 Oct; 27(9):886-92. PubMed ID: 15648557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blood coagulation and fibrinolysis in patients with hyperthyroidism.
    Erem C; Ersoz HO; Karti SS; Ukinç K; Hacihasanoglu A; Değer O; Telatar M
    J Endocrinol Invest; 2002 Apr; 25(4):345-50. PubMed ID: 12030606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.